Browse 493 Dystrophy clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Muscular dystrophy is not one disease but a group of more than 30 inherited conditions that weaken muscles over time, each caused by a different gene. Some, like Duchenne, begin in early childhood, while the most common adult form, myotonic dystrophy, may not appear until middle age. Most forms still have no treatment that slows them, and knowing the exact gene now opens the door to trials of gene therapies and medicines designed for one specific form.
Understanding and Enhancing Human Health and Movement
for
Spinal Cord Injury, Stroke (CVA) or Transient Ischemic Attack,
Location: Cleveland OH
Sponsor: Louis Stokes VA Medical Center
Sex: All
Age: 18+
Code: NCT07738978
Recruiting
Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer
for
Head and Neck Carcinoma of Unknown Primary,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT04754321
Phase 1, Recruiting
(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000
for
Epiretinal Membrane, Dry Age Related Macular Degeneration,
Location: Portland ME, Fort Lauderdale FL, Kansas City MO,
Sponsor: Carl Zeiss Meditec-Dublin CoCe
Sex: All
Age: 18+
Code: NCT07680244
Recruiting
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study
Get alerts for new trials in your area by subscribing now
Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).
for
Geographic Atrophy From Age-related Macular Degeneration
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 65 - 70+
Code: NCT07582042
Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration